Member Info for SolVista

Shes a NED..Their roles are minimal!

Looks like she's semi-retired..

Share price is stagnant.Considering Hvivo is considered to be a Fast growing early stage CRO frust😏

There's a small chance of success.

I'm sure they have shopped POLB-001 around to big pharma and biotechs.

Im not a chemist but I've seen Pharmaceutical companies invest after a Phase 1 trial if they see potential. (with bonus and royalty payments further down the road)

The capital raise was a good opportunity for Pharma to take 3% but none did.

The rns on Tuesday is/was basically irrelevant because it's years down the road.

I wonder how many got the rug pulled from underneath them.

Https://www.proactiveinvestors.co.uk/companies/news/1071904/hvivo-numbers-starting-to-stack-up-says-broker-1071904.html

POLB is only back to where it was trading last month after the disastrous breakup from Hookipa and down from 7.8p when the announced the reverse merger/buyout.

Hardly a glowing return on equity.

Haha you mean like Friel's buddy Michael Kelly who loaded up in the 13p range last year.

I'm going to say it in capitals.

I SAID APOLOGISE TO THE TOTALLY SHAREHOLDERS WHO HAVE MISINFORMED FOR YEARS.

Im not going to sift thru you posts on TLY but over the last few years you were constantly hyping it.

Jeez Sikh I suggest you go to the Totally forum and apologise for misleading shareholders over there rather than rehashing the same old verbal diarrhea here endlessly.

Hey America might be a mess but what about Europe,India,China.

You're a day late and a dollar short TB..

The coroner has already called the time of death on this 1

Hey when the Medical Director bought 4 million shares 5 weeks ago I almost took the bait

When the Medical Director bought over 4 million shares here 5 weeks ago I was seriously considering a position.

I looked closer at the balance sheet and couldn't understand why but I was still very tempted.

wow what a ****ty deal for hookipa shareholders.

All BS unless they close contracts

The gaps are getting way too wide..

I like Mo but either he closes contracts or he should consider his position.

We'll know if we get a TR-1..They diluted current shareholders by about 25% there should be filings.

So it will be a year before shareholders will know anything.

1 1/2 years until investors get to full trail results

The company earlier on Tuesday revealed plans to raise at least £4.1m, but confirmed around lunchtime that had conditionally raised £4.72m due to strong investor demand.

The fundraising comprised a placing of 134.8m shares, raising £3.37m, and a subscription of 53.8m, raising £1.35m. A bookbuild offer remains open until the end of play on Thursday, with the potential to raise an additional £100,000.

The funds will be used to provide the company financial runway into 2027, as well as going towards the Phase 2a trial of POLB 001, its oral preventative therapy for cancer immunotherapy-induced Cytokine Release Syndrome. The first patient in the trial is expected to be dosed in the second half of 2025, with topline data due in the second half of 2026.

20% dilution so will could drop more before the close.

What a debacle🙄

If this is the case why didn't they partially fund the trial?

'There are strong indications from Big Pharma to provide the necessary bispecific antibody, free of charge, to support the Phase 2a trial which represents a significant validation as to the industry interest in POLB 001 and its potential. The Company sees potential for partnering on positive data from this trial.'